(Q42599339)

English

Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder

scientific article published on 15 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

0 references

suicidal ideation

0 references

suicide prevention

0 references

0 references

obsessive-compulsive disorder

1 reference

based on heuristic

inferred from title

Christopher Pittenger

object named as

Christopher Pittenger

4

0 references

Philip R. Corlett

3

object named as

Philip R Corlett

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

author name string

Mark J Niciu

1

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Beth D G Grunschel

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Michael H Bloch

5

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

language of work or name

0 references

publication date

15 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

651-654

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

The incidence of unpleasant dreams after sub-anaesthetic ketamine.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Effects of ketamine in treatment-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Why do delusions persist?

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Toward a neurobiology of delusions

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Public health significance of mixed anxiety and depression: beyond current classification.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Psychiatric safety of ketamine in psychopharmacology research

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Comorbid anxiety as a suicide risk factor among depressed veterans

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Binding, relational memory, and recall of naturalistic events: a developmental perspective.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Ketamine : from medicine to misuse

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113486718

21 January 2018

Identifiers

10.1177/0269881113486718

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42599339&oldid=1962525281"